Rosa’s Derek Bartlett to Present Work on Mechanistic Modeling in Diabetes Drug Design at the AAPS Conference
Dr. Bartlett will discuss the use of modeling to evaluate combination therapies for diabetes, November 13th, 2013 in San Antonio, Texas.
San Carlos, CA, November 13, 2013 --(PR.com)-- Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced that Dr. Derek Bartlett, Senior Engineer, will present at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting (November 10th – 14th), San Antonio Texas. Dr. Bartlett’s poster is entitled “Application of a physiologically based model incorporating drug-specific PK modules to support optimization of GLP-1 receptor agonist combination therapies for type 2 diabetes.” He will illustrate how mechanistic models can be used to evaluate the impact of different methods of drug formulation and delivery and guide the rational design of combination therapy strategies.
About Rosa
Rosa helps clients with their critical decisions – from preclinical through clinical development – with the creation and use of mathematical models that simulate normal and disease physiology, drug action, patient variability, and trial outcomes. To address the full spectrum of R&D related challenges, Rosa offers customized approaches: classic pharmacokinetic/pharmacodynamic (PK/PD) models and Rosa’s innovative PhysioPD™ models. With these capabilities, Rosa’s clients participate in customized model creation, testing, and research simulations, retain the models, and acquire the ability to perform model research to inform decisions and better understand implications for their drug development programs. Rosa’s staff has unparalleled professional experience in applying modeling and simulation to accelerate drug development and have completed hundreds of engagements with clients in virtually all therapeutic areas. The Rosa team is unique in its breadth and depth of disease area experience, including metabolic diseases, oncology, inflammation, immune dysfunction, CNS, dermatology, and antibacterial/antiviral biology. For more information, visit www.rosaandco.com.
About Rosa
Rosa helps clients with their critical decisions – from preclinical through clinical development – with the creation and use of mathematical models that simulate normal and disease physiology, drug action, patient variability, and trial outcomes. To address the full spectrum of R&D related challenges, Rosa offers customized approaches: classic pharmacokinetic/pharmacodynamic (PK/PD) models and Rosa’s innovative PhysioPD™ models. With these capabilities, Rosa’s clients participate in customized model creation, testing, and research simulations, retain the models, and acquire the ability to perform model research to inform decisions and better understand implications for their drug development programs. Rosa’s staff has unparalleled professional experience in applying modeling and simulation to accelerate drug development and have completed hundreds of engagements with clients in virtually all therapeutic areas. The Rosa team is unique in its breadth and depth of disease area experience, including metabolic diseases, oncology, inflammation, immune dysfunction, CNS, dermatology, and antibacterial/antiviral biology. For more information, visit www.rosaandco.com.
Contact
Rosa & Co LLC
Rebecca Baillie
530-661-7476
http://www.rosaandco.com
Rebecca Baillie
530-661-7476
http://www.rosaandco.com
Contact
Categories